Cargando…
Drug Screening of Human GBM Spheroids in Brain Cancer Chip
Glioblastoma multiforme (GBM), an extremely invasive and high-grade (grade IV) glioma, is the most common and aggressive form of brain cancer. It has a poor prognosis, with a median overall survival of only 11 months in the general GBM population and 14.6 to 21 months in clinical trial participants...
Autores principales: | Akay, Metin, Hite, John, Avci, Naze Gul, Fan, Yantao, Akay, Yasemin, Lu, Guangrong, Zhu, Jay-Jiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194126/ https://www.ncbi.nlm.nih.gov/pubmed/30337660 http://dx.doi.org/10.1038/s41598-018-33641-2 |
Ejemplares similares
-
Engineering a Brain Cancer Chip for High-throughput Drug Screening
por: Fan, Yantao, et al.
Publicado: (2016) -
NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
por: Avci, Naze G., et al.
Publicado: (2020) -
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082
por: Pustchi, Sadaf E., et al.
Publicado: (2020) -
Investigating the effects of chronic perinatal alcohol and combined nicotine and alcohol exposure on dopaminergic and non-dopaminergic neurons in the VTA
por: Kazemi, Tina, et al.
Publicado: (2021) -
Investigating the influence of perinatal nicotine exposure on genetic profiles of neurons in the sub-regions of the VTA
por: Kazemi, Tina, et al.
Publicado: (2020)